NeuroPace (NPCE) Other Non Operating Income (2020 - 2026)
NeuroPace (NPCE) recorded quarterly Other Non Operating Income of -$165000.0 in Q1 2026, down 301.22% quarter-over-quarter from $82000.0 in Q3 2025, and down 101.22% on a YoY basis from $13.5 million in Q1 2025.
NeuroPace (NPCE) Other Non Operating Income (2020 - 2026) Analysis & Trends
NeuroPace's Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$165000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 101.22% year-over-year to -$165000.0; the TTM figure through Mar 2026 stood at -$569000.0 (down 432.75% YoY), while the FY2025 annual figure was -$486000.0, down 259.87% from the prior year.
- Other Non Operating Income was -$165000.0 for Q1 2026 at NeuroPace, down from $82000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $265000.0 in Q4 2023 to a low of -$817000.0 in Q1 2023.
- Historically, Other Non Operating Income has averaged -$62437.5 across 5 years, with a median of -$42500.0 in 2022.
- Biggest YoY gain for Other Non Operating Income was 281.51% in 2023; the steepest drop was 27133.33% in 2023.
- A 5-year view of Other Non Operating Income shows it stood at -$146000.0 in 2022, then soared by 281.51% to $265000.0 in 2023, then slumped by 132.45% to -$86000.0 in 2024, then surged by 195.35% to $82000.0 in 2025, then sank by 301.22% to -$165000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$165000.0 (Q1 2026), $82000.0 (Q3 2025), and -$486000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | NeuroPace | 527.50 Mn | 473.52 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -165,000.00 |
| Sep 30, 2025 | 82,000.00 |
| Jun 30, 2025 | -486,000.00 |
| Mar 31, 2025 | -82,000.00 |
| Dec 31, 2024 | -86,000.00 |
| Sep 30, 2024 | 219,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Dec 31, 2023 | 265,000.00 |
| Sep 30, 2023 | 115,000.00 |
| Jun 30, 2023 | 122,000.00 |
| Mar 31, 2023 | -817,000.00 |
| Dec 31, 2022 | -146,000.00 |
| Sep 30, 2022 | -103,000.00 |
| Jun 30, 2022 | -85,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -150,000.00 |
| Jun 30, 2021 | -2.12 Mn |
| Mar 31, 2021 | -3.11 Mn |